Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001552427 | SCV001773111 | pathogenic | not provided | 2024-08-07 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate a damaging effect, including significantly impaired substrate binding (PMID: 36216457); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 36216457) |
Genome |
RCV001265316 | SCV001443433 | pathogenic | Hogue-Janssens syndrome 1 | 2019-02-01 | no assertion criteria provided | provider interpretation | Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2019-02-01 and interpreted as Pathogenic. Variant was initially reported on 2018-01-05 by GTR ID of laboratory name 26957. The reporting laboratory might also submit to ClinVar. |
Genome |
RCV001552427 | SCV002818385 | not provided | not provided | no assertion provided | phenotyping only | Variant classified as Likely pathogenic and reported on 11-09-2017 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |